Article Text
Abstract
Introduction Externalising disorders are some of the most prevalent problems in childhood and particularly during adolescence that can change into more severe psychopathology in adulthood if left unattended. In the research literature, these disorders include attention deficit/hyperactivity disorder, oppositional/defiant disorder, conduct disorder and substance use disorders. The comorbidity prevalence of these disorders is significant and cannot be considered a random factor. The dimensional structure of psychopathology has always been studied by researchers to address disorder comorbidities and aetiology. There has always been controversy over the number of spectra and the lower levels. Currently, the new top-down, Hierarchical Taxonomy of Psychopathology model conceptualising psychopathology is being used, which is a dimensional classification system for the different spectra of psychopathology based on a combination of conceptual modelling and factor analysis of symptoms. This systematic review investigates the comorbidity prevalence of spectra of externalising disorders to provide valuable information and feedback on this model.
Methods and analysis This systematic review will include all the studies conducted from 1/1/1990 to 1/12/2020 to examine the prevalence and comorbidity of each of the externalising disorders in the general population, schools and outpatients using any instrument (questionnaires or interviews). There will be no language restrictions in selecting the studies. The studies are age restricted and must be conducted on adolescents only, but there are no restrictions on the gender and nationality of the participants.
Ethics and dissemination This systematic review is based on previously published articles and therefore will not require ethical approval. The results of the systematic review will be disseminated as publication in a peer-reviewed journal and conference presentation.
PROSPERO registration number CRD42022327629.
- child & adolescent psychiatry
- epidemiology
- substance misuse
This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
Statistics from Altmetric.com
STRENGTHS AND LIMITATIONS OF THIS STUDY
No language restrictions will be mentioned.
Use of comprehensive search resources and the inclusion of grey literature (eg, preprints).
Conduct the methodological quality assessment, heterogeneity assessment and the sensitivity analysis in the main study of the systematic review and meta-analysis.
Study selection, data extraction and risk of bias assessment will be performed independently by two researchers, which will ensure that all relevant studies are included without personal biases.
A potential limitation of this review may be the high methodological heterogeneity.
Introduction
Externalising disorders refer to a group of behavioural disorders appearing during childhood that represent the child’s negative conduct toward his external environment.1 In the research literature, externalising disorders include attention deficit/hyperactivity disorder (ADHD), oppositional/defiant disorder (ODD) and conduct disorder (CD).2 Evaluating the structure of these disorders usually demonstrates the connection between the tendency toward disinhibition and high-risk impulsive behaviours.3 These are the most prevalent reasons for referring children and adolescents to mental health centres, burdening families and individuals with heavy costs.4 Based on the existing studies, at least 5%–10% of school-aged children and adolescents have serious ongoing behavioural and emotional problems. A significant percentage of these problems can persist for years to come. The self-report by adolescents shows a high level of alcohol consumption, substance use, bullying and aggressiveness. These statistics are rather elevated even in industrialised countries.5 The systematic analysis of the Global Burden of Disease6 assessed the disability-adjusted life year and found the age-standardised rate for CD as 78.2 per 100 000 in 2005 and 79.3 per 100 000 in 2015. The proportion for ADHD was 8.6 in 2005 and 8.3 in 2015. For the abuse of drugs, alcohol, medicine, cocaine, amphetamine, hashish and other substances, the overall rate was reported as 597.7 in 2005 and 803.9 in 2015. The Global Burden of Disease Study7 also reported the age-standardised death rate for the abuse of drugs, alcohol, medicine, cocaine, amphetamine, hashish and other substances as 4.9 per 100 000 in 1990 and 5.6 per 100 000 in 2013.
Examining the prevalence of these disorders in clinical and non-clinical samples of children, adolescents and adults revealed a high prevalence of comorbidity.8 The prevalence of comorbidity was above 50% for ODD, CD, ADHD and substance use disorders. In addition to the high prevalence of comorbidity of these disorders, a high proportion of comorbidity was also reported between these and internalising disorders (ie, stress and depression). Epidemiological data showed that the concurrence of two or more disorders cannot be attributed to mere random factors.9 The comorbidity data have created a serious challenge for classification systems and aetiological hypotheses.10 Psychiatric disorder comorbidities, including externalising disorders, were rarely examined before the publication of DSM-III-R (diagnostic and statistical manual of mental disorders) in 1987. Previous versions of DSM used the diagnostic hierarchy, which usually meant comorbidities were ignored and not recorded. Eliminating the diagnostic hierarchy significantly increased the prevalence of comorbidities, and there was then a substantial rise in studies addressing the patterns of these diagnostic overlaps. The number of articles including the word ‘comorbidity’ went from 0 in 1985 to 243 in 1993 and over 1500 in 2013. This is an ongoing trend. The comorbidity and coexistence of two or more disorders have been the main challenge of the DSM diagnostic system and other disorder classification systems.11
Krueger suggested that comorbidity in psychiatric disorders is caused by fundamental psychopathological processes and focused his research on these main processes rather than their manifestations as separate disorders.12 By focusing on symptoms rather than disorders, bottom-up models or paradigms emerged as opposed to top-down paradigms. In bottom-up paradigms, the focus is on empirical data, from which the concept of psychopathology is derived. In contrast, top-down paradigms (such as DSM and ICD (International Statistical Classification of Diseases and Related Health Problems) diagnostic systems) prioritise the conceptualisation of the nature and structure of psychopathology. In bottom-up models, extensive factor analyses of psychiatric symptoms were performed to discover and explain the liabilities associated with the structure of psychopathology. The results of these extensive factor analyses have been varying.13
By modelling the hierarchical relationships between disorders and using the exploratory factor analysis for behavioural, emotional, social and thought problems in children and adolescents, Achenbach identified a bifactor model. The first factor included an external pole (involving aggressive and law-breaking behaviours) and an internal pole (involving intrapersonal disorders such as anxiety, depression and physical complaints without a medical reason). The second factor was unipolar and was presented as severe psychopathology that included problems such as strange behaviours, hallucinations, delusions, feeling harassed, confusion, fear of own impulses, compulsion and obsession.13 Inspired by the Achenbach model, Krueger et al suggested that the relationship between disorders reflects the two dimensions of internalisation and externalisation, which represent common genetic and environmental effects in disorders related to each spectrum.14 In adolescent samples, the internalisation–externalisation model of psychopathology has also been corroborated by other research. Caspi et al15 found evidence of a bifactor model that includes a general psychopathological factor and a second factor that includes the spectrum of internalisation and externalisation. In this context, individual symptoms are organised into distinct diagnoses. The extensive research by Caspi et al using adolescent samples supported this bifactor model. The symptoms are correlated in the bifactor model because all of these symptoms have general psychopathology in common as their feature. Overall, the mean score for the p factor indicates a general tendency towards psychopathology, and the mean score for each spectrum indicates a tendency towards problems associated with that spectrum. For example, in the externalisation spectrum, the probability of aggressive behaviours and behavioural problems is higher.14 The general psychopathology factor can explain the problems encountered in identifying the unique causes, consequences, biomarkers and treatment of individual disorders. This general factor emphasises the importance and usefulness of transdiagnostic treatment and comprehensive prevention approaches and can address multiple problems in a single framework.15 The presence of this general psychopathology indicates a positive correlation between these spectra.
Another model showed that the structure of psychological disorders can be summarised in three dimensions: (1) internal liability for depression and anxiety, (2) external liability for behavioural disorders and substance use disorders, and (3) liability for psychosis symptoms. This finding showed that in addition to the established dimensions of internal and external liabilities, there is a distinct third dimension that is characterised by confused thoughts.15 Of course, there is still some debate about the cause of thought disorder. For example, Caspi et al argued that thought disorder is not an independent dimension, rather it indicates the overall severity of general psychopathology.16
In addition to identifying the dimensions, numerous studies have examined the subfactors in each spectrum and have yielded disparate results. For example, some studies have not proposed any subfactors for externalising disorders, but internalising disorders have been divided into three subfactors, including distress, fear and eating.17 In some research, the externalising spectra have been modelled as an individual latent factor. Nevertheless, studies have shown that separate subfactors exist for this dimension, such as the bifactor model which distinguishes the subfactors of oppositional and defiant conduct from social norms.18
Studies investigating the latent structure of psychiatric disorders in children and adults have also shown that the underlying factors showing internalising and externalising liabilities in psychopathology explain comorbidity patterns in psychiatric disorders very well.19 Nonetheless, there is still controversy about the lower-level factors, but since there seems to be persistence in the latent structure of disorders between adolescence and adulthood, interventions aimed at the prevention and treatment of psychopathology in adolescents can reduce the risk of psychiatric disorders in adulthood.19
The new top-down models use the factor analysis method to construct dimensional scales similar to the scales based on the bottom-up models described earlier.13 The Hierarchical Taxonomy of Psychopathology (HiTOP) framework is used with the aim of integrating research on the experimental organisation of psychopathology to set up a comprehensive descriptive system. This hierarchical and dimensional classification system can solve problems related to the comorbidity of disorders, heterogeneity within the disorders, diagnostic instability and subthreshold symptoms.20 Compared with DSM diagnoses, the transdiagnostic dimensions of HiTOP explain heritability patterns, biological neural processes, functional disorders, environmental risk factors and variations in response to therapy. The HiTOP framework consists of five hierarchically organised levels. At the lowest levels of the hierarchy are signs and symptoms that combine to reflect the broader dimensions of psychopathology, from syndromes/disorders (such as the DSM diagnoses) to subfactors (such as fear and distress). The spectra (such as antagonism and detachment) and higher-level construct are two levels higher, which is a common factor in most forms of psychopathology.21
The external superspectrum consists of two spectra: (1) disinhibited externalising and (2) antagonistic externalising. The disinhibited externalising spectrum includes impulse-based tendencies regardless of potential consequences. Empirically, disinhibition is associated with socially forbidden behaviours that are psychologically aligned with the core of the structure, such as excessive use of psychedelic drugs with minimal regard for future consequences. The antagonistic externalising spectrum includes tendencies towards interpersonal antagonism and deliberately hurting other people with the least regard for their rights and feelings.20 Kotov et al22 suggested that disinhibition is above all associated with the issue of using drugs and includes substance use disorders, while conflict is prominent in aggressive disorders, which include CD, ODD, ADHD, intermittent explosive disorder and antisocial personality disorder.
Research on the validity of the model is still underway. Assuming the existence of a dimensional hierarchy model, it is expected that the prevalence of comorbidities in the subspectra would be higher and less correlated with the other spectra. Also, considering the general factor of psychopathology, a positive correlation is expected between the prevalence of comorbidities in the externalising subspectrum with the other spectra. Despite the sensitivity of the adolescence period and its importance in the formation and continuation of subsequent pathologies, we see fewer studies in this area about the prevalence of these disorders and their structure at this age. Therefore, the purpose of this systematic review is to examine the prevalence of comorbidities of externalising disorders in adolescence.
To the best of our knowledge, there was no relevant systematic review examining the prevalence of comorbidities of externalising disorders. Nevertheless, some systematic reviews have examined the comorbidity of one disorder from the externalising spectrum. A systematic review of the comorbidity of electronic cigarette smoking and mental health problems examined 40 articles including adolescents and young adult groups by focusing on three spectra of internalising disorders (depression and anxiety, suicide and eating disorders), externalising disorders (ADHD and CD) and transdiagnostic concepts (impulsivity and perceived stress). This review study showed that electronic cigarette smoking is associated with an increased prevalence of mental health problems, especially in adolescents. The time frame of the search was limited and the reviewed studies were only cross-sectional.23
Another systematic review study also examined the prevalence of ODD comorbidity in children and adolescents.24 Their results showed that although ODD occurs in all age groups, its comorbidity rates differ in the special age group of children and adolescents, and also boys and girls have different comorbidity patterns. The studies reviewed in the research were limited to English-language studies and limited sources were used for the search. Dullur et al25 conducted a systematic review to examine comorbidity rates between ADHD and gaming disorder. They demonstrated a relationship between these two disorders by reviewing 29 observational studies, and the relationship between this disorder and ADHD was greater than the other subclusters. Their sources were limited and no meta-analysis was carried out by them either. In another systematic review and meta-analysis, Nazar et al26 examined the comorbidity of ADHD and eating disorders. They reviewed 16 articles (12 studies on eating disorders in people with ADHD and 4 articles on ADHD in people with eating disorders) and found that the prevalence of eating disorders is increasing in people with ADHD (3.82). This finding indicates that people with ADHD have a relatively high risk of developing an eating disorder. In a meta-analysis and meta-regression analysis, the prevalence of comorbidity of ADHD and substance use disorders was examined in 29 English-language studies, and the results showed that the prevalence of comorbidity was 23.1. The study sources were limited in that article as well, and no systematic review was performed by its researchers. In another meta-analysis, Tung et al27 examined the comorbidity pattern in girls with ADHD. In that study, the comorbidity of internalising and externalising disorders was studied and the review of 18 articles showed that the comorbidity of this disorder with other disorders of the externalising spectrum (ODD: 5.6, CD: 9.4) was higher than with disorders of the internalising spectrum (anxiety: 3.2, depression: 4.2). On the same subject, in a systematic review protocol and meta-analysis, Catalá-López et al28 examined the prevalence and comorbidities of ADHD. Their study included cross-sectional observational studies of the general population and the school environment. In the first stage, the purpose of the study was to examine the prevalence of ADHD. In the second stage, it examined the prevalence of any physical or psychological problems associated with ADHD. The heterogeneity causes were also evaluated.
Among previous relevant systematic reviews and meta-analysis articles, only two articles have used both the systematic review and meta-analysis approaches. Most of these articles had language limitations and most had not used grey literature. In a few studies, the selection process, quality assessment and data extraction were all duplicated. Also, in none of the studies were all three of these steps duplicated simultaneously. Moreover, limited search terms had been used in all the studies. Compared with these previous studies and based on the prior principle, a systematic review, meta-analysis and database search were carried out in this study without any language restrictions and with consideration for grey literature resources to examine the prevalence of comorbidity of externalising disorders (ADHD, CD, substance use disorders and ODD) in adolescents.
Objectives
This research aims to examine the prevalence of comorbidity of the externalising spectrum of disorders among adolescents, divided into ADHD, CD, substance use disorders and ODD.
The secondary objectives of the research include:
Investigating the prevalence of comorbidity of externalising disorders of the other spectra (internalising, externalising and thought disorders).
Investigating the prevalence of comorbidity of externalising disorders (comorbidity of ADHD, CD, substance use disorders and ODD).
Examining the prevalence of comorbidity of externalising disorders by gender.
Studying the disparities in findings and investigating the causes.
Methods
This systematic review study will be conducted according to the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols guidelines (online supplemental file 1). The study protocol has been registered under the code CRD42022327629 on the PROSPERO website.
Supplemental material
Eligibility criteria
Type of study
This systematic review will include all the studies examining the prevalence of comorbidity of each of the externalising disorders, including all the observational studies, survey research and cohort (to evaluate lifetime prevalence), cross-sectional, and correlational studies conducted on the prevalence of comorbidities in the general population and school-based population using any instrument (questionnaires or interviews). There will be no language restrictions for the studies. Qualitative studies, case studies, letters, editorials and studies on hospital (clinical)-based populations will be excluded from this study.
Subjects
Studies related to the adolescent age group (13–18 years) will be included in the study. The studies will not be limited in terms of gender and nationality.
Conditions or outcome(s) of interest
The main indicator is the prevalence of comorbid externalising disorders, indicating the number of people who have both an externalising disorder (ADHD, CD, ODD or substance use disorders) and another psychiatric disorder relative to the population at a time point.
Definitions
Studies complying with the DSM definitions of ADHD, CD, ODD and substance use disorders will be included. Substance use disorders include all substances (alcohol, hashish, heroin, marijuana, etc) and are not limited to cigarettes.
Sampling method
Studies with at least 25 subjects that have used any random or non-random sampling method will be included in this study.
Search strategy
The literature will be searched using four strategies.
The first strategy involves searching electronic databases, including PsycINFO, MEDLINE, Embase, Scopus, ProQuest, Web of Science and Google Scholar from 1/1/1990 to /1/1/2022. Relevant keywords are obtained by using controlled vocabularies, Medical Subject Headings, Emtree and PsycINFO thesaurus system, the three-stage method and the free-text method, including an examination of previous systematic reviews and asking experts.
The second strategy involves searching the reference lists of all the selected studies to be included in the systematic review to ensure that no relevant study is missed.
The third strategy is searching the grey literature (other sources such as conference papers and dissertations).
The fourth strategy is searching key journals. To be more comprehensive in accessing resources, first, we entered the syntax in the search section of the Scopus database. In the pages showing the search results, we used the journal filter on the left side to display the journals by the most syntax-related articles. PLOS One and the Journal of Affective Disorders were the two journals with the most related articles. We will consider these two journals as key journals.
The search syntax developed to be used for the PsycINFO database is presented in online supplemental file 2. This search syntax will be modified and will be used for other electronic databases.
Supplemental material
Data collection and analysis
Selection process
Following a systematic search of sources and the sources’ registration in the Mendelian program, the studies will be given to two evaluators. In the preliminary screening phase, the studies will be evaluated by two raters based on their titles and abstracts as well as the inclusion and exclusion criteria; each rater will categorise the studies independently (relevant, irrelevant, uncertain). Inter-rater disagreements will be resolved through discussion and consensus. If the disagreement persists, the third-party strategy will be used to resolve the conflict. In the next step, the full text of those studies which were labelled as ‘uncertain’ in terms of their relevance will be reviewed by two raters based on the inclusion and exclusion criteria to determine their status. In the case of disagreements at this stage, the third-party strategy will again be used.
There are no language restrictions for the studies and articles will be translated if necessary.
Methodological quality (risk of bias) assessment of the preliminary studies
The methodological quality assessment of the identified articles will be carried out by two independent raters using the JBI checklist (critical appraisal tools for prevalence studies).29 The checklist included nine questions which considered the following items: the appropriateness of the sample frame, the appropriateness of the way of choosing, the sufficiency of the sample size, the accurate description of the study subject, valid methods for identification of the condition, the appropriateness of data analysis to cover the identified sample, condition measured standard and reliable for all participants, the appropriateness of statistical analysis and the sufficiency of response rate.
Each rater will fill out the form for each article. Disagreements between the raters will be resolved through discussion and consensus. If disagreements persist, the third-party strategy will be used to resolve the issue.
Data extraction and data synthesis
Data will be extracted by two independent raters based on the designed data collection form. Data will be collected as follows:
Study identification data (first author, year of publication, publishing journal, type of study, geographical location).
Background information (age, gender, number of participants, inclusion and exclusion criteria, level of education).
Information on the primary objective (prevalence of comorbidity of externalising disorders, including ADHD, CD, ODD and substance use disorders) and secondary objectives (prevalence of comorbidity of externalising disorders, prevalence of comorbidity with other spectra, prevalence rates by gender).
To evaluate the effects of risk of bias on the results of the total study, we will consider a score for each of the JBI checklist questions. The ‘yes’ option will receive 1 point and the ‘no’, ‘not clear’ and ‘not applicable’ options will not receive any. The studies will be divided into the high and low quality on the basis of median. The studies which are upper than the median will be considered as the high-quality group. Then, we will contrast the composition of high-quality group with the composition of the total group. Thus, the differences will be designated.
The combination of data (meta-analysis) consists mainly of the denominator of the prevalence fraction (number of cases with disorders, total number of cases examined). In cases where data related to the primary objectives are not reported in the article, if the data are shown as a graph, the web plot digitiser will be used in the first step for their examination, and the graphic data will be converted to numerical data. In the second step, if the required data have not been reported in the original articles, the corresponding author will be contacted. If, after three contacts set 1 week–10 days apart, no answer is received to the correspondence, the article will be excluded from the study.
The main indicator in this study is the prevalence of comorbidity, and the meta-analysis will be performed with at least four relevant studies. The prevalence data will be combined using Stata V.13 and the Metaprop command. Due to methodological similarities and differences, the fixed-effects model or the random-effects model will be selected to determine the combination model. A forest plot will be used to display the effect size combination.
Cochran’s Q test and the I2 statistic will be used to assess any heterogeneity in the results of the studies and their assessment. The Higgins classification will be used to classify heterogeneity as follows: 0–24.5 indicate mild heterogeneity, 25–50 moderate heterogeneity, 50–74.5 substantial heterogeneity and 75–100 considerable heterogeneity.
Subgroup analysis will be used in order to influence different factors on prevalence. The variables of gender, measure (interview vs questionnaire) and methodological quality will be considered as prespecified subgroup analysis.
To assess the publication bias, the following steps will be used:
Funnel charts: this method will not be used if the total number of studies is less than 10. If some degree of heterogeneity is observed in the scattering of the points in the funnel chart, the two methods in the next step will be used.
In the second step, the Begg’s and Egger’s statistical tests will be used. If either of the two tests has a p value smaller than 0.1, then the method in the next step will be used to correct this bias.
The trim-and-fill method for publication bias will be used at this stage.
The leave-one-out method will be used for sensitivity analysis of the meta-analysis using the metaninf command in Stata.
Patient and public involvement
Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.
Ethics and dissemination
This systematic review is based on previously published articles and therefore will not be required ethical approval. The results of the systematic review will be disseminated as publication in a peer-reviewed journal and conference presentation.
Discussion
In the present systematic review and meta-analysis, we will review the prevalence of comorbidity rates of externalising disorders (including ADHD, CD, ODD and substance use disorders) during adolescence and will examine the comorbidity status of these disorders with respect to the other spectra and within the spectra themselves. As there seems to be continuity in the latent structure of disorders from adolescence to adulthood, a better identification and treatment of common risk factors can reduce the risk of psychiatric disorders in adulthood. The results of this study can provide theoretical support for the new HiTOP model and help better understand psychopathologies in adolescents. These results will also be useful for researchers working in the pathology and treatment of externalising disorders, in particular the new wave of transdiagnostic therapies.
Ethics statements
Patient consent for publication
References
Supplementary materials
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Footnotes
Contributors AP and MN conceived the study idea and design. MN, AP, HP, BD and NH drafted the first protocol. HP and MN reviewed the protocol. MN, AP, HP, BD and NH have developed the search strategy and methods of the systematic review. MN, AP, HP, BD and NH have read and approved the final version of the manuscript. All authors are in agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Patient and public involvement Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.
Provenance and peer review Not commissioned; externally peer reviewed.
Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.